Clinical Trials Browser

Phase 2 × INDUSTRY × peginesatide × Clear all

NCT00272662 2012-12-21

Study of Subcutaneously Administered Peginesatide in Anemic Cancer Patients Receiving Chemotherapy

Phase 2 Completed

Classical hematology

Anemia, Neoplasms